C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems

Patents for C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems (11,865)
01/2005
01/06/2005	US20050004360 Compounds and methods for modulation of estrogen receptors
01/06/2005	US20050004230 Retroviral protease inhibitors
01/06/2005	US20050004167 Such as dibenzofuran-2-carboxylic acid 2-(phenylsulfonyl)hydrazide
01/06/2005	US20050004164 2-Cyanopropanoic acid amide and ester derivatives and methods of their use
01/05/2005	EP1492771A1 Quinoline and isoquinoline derivatives, method for the production thereof and use thereof as anti-inflammatory agents
01/05/2005	EP1274687B1 1,2,3,4- tetrahydroisoquinoline derivatives
01/05/2005	CN1183117C Intermediates for making HIV-protease inhibitors and method of making HIV-protease inhibitors
01/05/2005	CN1183116C Substituted isoquinoline derivatives and pharmaceutical composition containing them, its preparation method and use
01/05/2005	CN1183107C Alkynyl containing hydroxamic acid compounds as TACE inhibitors
01/04/2005	US6838465 N-acyltetrahydroisoquinoline derivatives
12/2004
12/30/2004	US20040266817 3-Substituted 6,7-dihydroxytetrahydroisoquinoline derivatives for use as antibacterial agents
12/29/2004	WO2004113391A2 Improved pharmaceutical drug candidates and methods for preparation thereof
12/29/2004	WO2004113330A1 Immunosuppressant compounds and compositions
12/29/2004	WO2004113302A1 N-substituted 6,8-dialkoxy-1,2,3,4-tetrahydro-1h-isoquinoline as potassium channels modulators
12/29/2004	WO2004113301A1 Glyt1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders
12/29/2004	WO2004113277A2 Methods and compositions for treating amyloid-related diseases
12/29/2004	WO2004113275A2 Methods and compositions for treating amyloid-related diseases
12/29/2004	WO2004112793A1 Guanidino-substituted quinazolinone compounds as mc4-r agonists
12/29/2004	EP1491532A1 Heteroaryl diazacycloalkanes as cholinergic ligands at nicotinic acetyloholine receptors
12/29/2004	EP1490341A1 Novel adamantane derivatives
12/29/2004	EP1490340A1 Heteroaromatic urea derivatives as vr-1 receptor modulators for treating pain
12/29/2004	EP1490339A1 Novel chalcone derivatives and uses thereof
12/29/2004	EP1490062A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
12/29/2004	CN1182121C Compound with activity for resisting platelet aggregation and its preparation method
12/29/2004	CA2529524A1 Substituted piperidine compounds and methods of their use
12/29/2004	CA2529257A1 Methods and compositions for treating amyloid-related diseases
12/29/2004	CA2529256A1 Methods and compositions for treating amyloid-related diseases
12/29/2004	CA2524700A1 N-substituted 6,8-dialkoxy-1,2,3,4-tetrahydro-1h-isoquinoline as potassium channels modulators
12/29/2004	CA2524027A1 Immunosuppressant compounds and compositions
12/29/2004	CA2523015A1 Guanidino-substituted quinazolinone compounds as mc4-r agonists
12/28/2004	US6835739 Benzamides and related inhibitors of factor Xa
12/28/2004	US6835725 Cyanine dye containing heterocylic rings; satisfies light stability, favorable signal/noise rato, damage free application to the substrate material, use in the information layer in a write-once optical data carrier
12/28/2004	US6835469 Phosphorescent compounds and devices comprising the same
12/28/2004	CA2126072C Tri-substituted phenyl derivatives and processes for their preparation
12/23/2004	WO2004111010A1 Isoquinoline -1,3,4-trione, the synthetic method and the use thereof
12/23/2004	WO2004111009A1 Fused compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor
12/23/2004	WO2004110986A1 Benzamide derivative or salt thereof
12/23/2004	WO2004099150A3 3-(1-naphthyl)-2-cyanopropanoic acid derivatives as estrogen receptor ligands
12/23/2004	US20040259912 N-(4-benzhydryloxy-3-isobutyrylphenyl)-N'-(3,4-dimethoxyphenyl)urea for example; vanilloid receptor agonists; use as analgesic and or for treating urinary frequency and/or urinary incontinence
12/23/2004	US20040259910 Glutamine fructose-y-phosphate amidotransferase (GFAT) inhibitors
12/23/2004	US20040259804 (Substituted)Acyl dipeptidyl inhibitors of the ICE/ced-3 family of cysteine proteases
12/23/2004	CA2756058A1 Fused compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor
12/23/2004	CA2526872A1 Fused compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor
12/23/2004	CA2526387A1 Benzamide derivative or salt thereof
12/22/2004	EP1489071A1 N-substituted, 3,4-dihydro-1H-isoquinoline as potassium channels modulators
12/22/2004	EP1487801A1 7-arylsulfonamido-2,3,4,5-tetrahydro-1h-benzo[d]azepine derivatives with 5-ht6 receptor affinity for the treatment of cns disorders
12/22/2004	EP1487798A1 Substituted tetrahydroisoquinolines as c5a receptor modulators
12/22/2004	EP1487795A2 Synthesis of enantiomerically pure amino-substituted fused bicyclic rings
12/22/2004	EP1487449A1 Tyrosyl derivatives and their use as p2x7 receptor modulators
12/16/2004	WO2004108682A2 Tetrahydroisoquinolines as antagonists of the 5ht1b receptor
12/16/2004	WO2004108681A1 Nitrogen-containing heteroaryl compounds and their use in increasing endogenous erythropoietin
12/16/2004	WO2004108663A1 N-alkynyl-2- (substituted aryloxy) alkylthioamide derivatives as fungicides
12/16/2004	WO2004108645A1 Method for the treatment or prevention of lower urinary tract symptoms
12/16/2004	WO2003063797A8 Cycloalkyl inhibitors of potassium channel function
12/16/2004	US20040254216 Inhibitors of p38
12/16/2004	US20040254215 Novel nitrogen-containing heteroaryl compounds and methods of use thereof
12/16/2004	US20040254214 7-Amido-isoindolyl compounds and their pharmaceutical uses
12/16/2004	US20040254193 Novel tetrahydroquinolines
12/16/2004	US20040254188 such as N-(5-tert-butyl-2,3-dihydro-1H-inden-1-yl)-N'-5-isoquinolinylurea; for treating pain, inflammatory thermal hyperalgesia, urinary incontinence, or bladder overactivity
12/16/2004	CA2528756A1 Tetrahydroisoquinolines as antagonists of the 5ht1b receptor
12/16/2004	CA2527313A1 N-alkynyl-2-(substituted aryloxy) alkylthioamide derivatives as fungicides
12/15/2004	EP1485370A1 Amino-derivatives as novel inhibitors of histone deacetylase
12/15/2004	EP1485364A1 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
12/15/2004	EP1485357A1 Process for asymmetric hydrogenation of hexahydroquinoline salts
12/15/2004	EP1485356A1 NON-PEPTIDE GnRH ANTAGONISTS
12/15/2004	EP1485353A1 New inhibitors of histone deacetylase
12/15/2004	EP1485348A1 Carbonylamino-derivatives as novel inhibitors of histone deacetylase
12/15/2004	EP1485099A1 Inhibitors of histone deacetylase
12/15/2004	EP1226137B8 Phenyl- and pyridyl-tetrahydro-pyridines having tnf inhibiting activity
12/15/2004	CN1554649A Metabotropic glutamate receptor antagonists for treating central nervous system diseases
12/15/2004	CN1179948C HIV protease inhibitors
12/14/2004	US6831080 Cinnamide derivatives as KCNQ potassium channel modulators
12/09/2004	WO2004106305A1 New p2x7 receptor antagonists and their use
12/09/2004	US20040248989 Method for the treatment or prevention of lower urinary tract symptoms
12/09/2004	US20040248933 tertiary carbocyclic amines such as 4,7-diphenyl-2-methyl-1,2,3,4-tetrahydroisoquinoline, having preferential binding norepinephrine transporter protein (NET) over the other neurotransmitter transporters; side effect reduction
12/09/2004	US20040248932 Use of aryl- and heteroaryl-substituted tetrahydroisoquinolines in the treatment of chronic and neuropathic pain, migraine headaches, and urge, stress and mixed urinary incontinence
12/09/2004	US20040248895 Novel guanidino compounds
12/09/2004	US20040248872 Safe for agricultural or gardening use; effective against insects and mammals
12/08/2004	EP1484320A1 Jnk inhibitor
12/08/2004	EP1483244A1 Cyclic n-substituted alpha iminocarboxylic acids for selectively inhibiting collagenase
12/08/2004	EP1483233A2 Substituted tetrahydroisoquinoline compounds, methods of making, and their use
12/02/2004	WO2004103967A2 Thiocarbamate inhibitors of alpha-4 integrins
12/02/2004	WO2004103961A2 Sulfated bis-cyclic agents
12/02/2004	US20040242572 New carboxamide compounds having melanin concentrating hormone antagonistic activity, pharmaceutical preparations comprising these compounds and process for their manufacture
12/02/2004	CA2525934A1 Thiocarbamate inhibitors of alpha-4 integrins
12/01/2004	EP1481968A2 Cell adhesion-inhibiting anti-inflammatory and immune-suppressive compounds
12/01/2004	EP1480999A2 (substituted)acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases
12/01/2004	EP1480971A1 Isoquinoline derivatives
12/01/2004	EP1480954A1 Vanilloid receptor modulators
12/01/2004	EP1480941A2 Urea derivatives as hiv aspartyl protease inhibitors
12/01/2004	EP0886637B1 Inhibitors of microsomal triglyceride transfer protein and method
12/01/2004	CN1550496A Acetylenic alpha-amino acid-based sulfamide hydroxamic acid TACE inhibitors
11/2004
11/30/2004	US6826033 Beta 3 adrenergic receptor agonists; treatment of pollakiuria, urinary incontinence, obesity or diabetes
11/30/2004	US6825354 Osteoporosis; rheumatic diseases
11/30/2004	US6825351 Selective hydrogenation of amino-substituted fused bicyclic aromatic ring system, preparation of racemic amino substituted fused bicyclic ring system via nitrosation, enzymatic resolution of racemic mixture to produce (r)- and (s)-forms
11/30/2004	US6825228 To treat infections by gram-positive bacteria, in particular drug- resistant strains
11/30/2004	US6825213 β3-adrenoreceptor agonists, agonist compositions and methods of using
11/30/2004	US6825189 Treating withdrawal symptoms caused by smoking cessation
11/30/2004	US6825184 For use as anti-inflammatory agents
11/30/2004	US6825181 Orally administrated to exhibit a strong anticoagulant effect by inhibiting activated blood- coagulation factor x

1 ... 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 ... 119